Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 1000 of 1322 entries
View as:

Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05711056 Org: User:
Start: 08/30/23 End: 08/31/26 Due: 08/31/27

Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05464810 Org: User:
Start: 09/02/22 End: 04/15/27 Due: 04/15/28

Neostigmine For Snoring During DISE

Phase: N/A Priority: Normal
NCT ID: NCT03316963 Org: User:
Start: 11/14/17 End: 03/19/19 Due: 03/19/20

Neurovascular Transduction During Exercise in Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02947750 Org: User:
Start: 10/31/16 End: 01/31/26 Due: 01/31/27

A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01485835 Org: User:
Start: 01/31/12 End: 09/30/15 Due: 09/30/16

Dietary Effects of Sulfur Amino Acids

Phase: N/A Priority: Normal
NCT ID: NCT00228618 Org: User:
Start: 01/31/05 End: 01/31/09 Due: 01/31/10

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab

Phase: N/A Priority: Normal
NCT ID: NCT00208975 Org: User:
Start: 07/31/02 End: 09/30/11 Due: 09/30/12

Effect of Cola on Urinary Stone Risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT00289120 Org: User:
Start: 11/30/03 End: 10/31/11 Due: 10/31/12

Thrombin Generation in Neonates

Phase: N/A Priority: Normal
NCT ID: NCT00165906 Org: User:
Start: 01/31/05 End: 01/31/09 Due: 01/31/10

The Impact of Improved WASH in Schools on Absence, Diarrhea and Helminth Infection in Lao PDR

Phase: N/A Priority: Normal
NCT ID: NCT02342860 Org: User:
Start: 09/30/14 End: 03/31/17 Due: 03/31/18

A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects with Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06752928 Org: User:
Start: 02/28/25 End: 10/31/26 Due: 10/31/27

The Primary Prevention of Intimate Partner Violence

Phase: N/A Priority: Normal
NCT ID: NCT06811922 Org: User:
Start: 05/31/25 End: 10/31/27 Due: 10/31/28

THRIVE Breast Cancer App Study

Phase: N/A Priority: Normal
NCT ID: NCT03592771 Org: User:
Start: 11/15/18 End: 06/30/22 Due: 06/30/23

Dementia-Friendly Faith Villages to Support African American Families

Phase: N/A Priority: Normal
NCT ID: NCT04983693 Org: User:
Start: 05/01/19 End: 04/01/22 Due: 04/01/23

Assessment of Cloth Face Coverings as Source Control Under Laboratory and Simulated Field Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05216939 Org: User:
Start: 11/08/21 End: 02/22/22 Due: 02/22/23

Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04780477 Org: User:
Start: 06/29/21 End: 12/31/25 Due: 12/31/26

A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01334710 Org: User:
Start: 03/31/11 End: 12/31/11 Due: 12/31/12

Caregiver as Navigator: Develop Skills Online (CAN-DO)

Phase: N/A Priority: Normal
NCT ID: NCT06177990 Org: User:
Start: 12/26/24 End: 03/31/28 Due: 03/31/29

Isatuximab As Upfront Therapy for the Treatment of High Risk AL Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT04754945 Org: User:
Start: 04/28/21 End: 07/24/26 Due: 07/24/27

SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05256706 Org: User:
Start: 02/03/22 End: 12/09/23 Due: 12/09/24

Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry

Phase: N/A Priority: Normal
NCT ID: NCT05999084 Org: User:
Start: 03/06/25 End: 07/31/28 Due: 07/31/29

Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05204160 Org: User:
Start: 04/11/22 End: 02/27/24 Due: 02/27/25

Development and Adaptation of I-STRONG for SCD

Phase: N/A Priority: Normal
NCT ID: NCT06110754 Org: User:
Start: 10/24/23 End: 06/14/24 Due: 06/14/25

Phenotype Depression Study

Phase: N/A Priority: Normal
NCT ID: NCT01426997 Org: User:
Start: 07/31/10 End: 05/31/16 Due: 05/31/17

Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership

Phase: N/A Priority: Normal
NCT ID: NCT00336869 Org: User:
Start: 12/31/05 End: 01/31/10 Due: 01/31/11